KATRINA MILLER: Open Payments
NPI 1477154367 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,149 in 54 payments from 20 companies in 2025. Trend: 2023 $620 · 2024 $1,291 · 2025 $1,149
Food & beverage: $1,049Education: $100
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $244 |
| Astellas Pharma US Inc | 9 | $184 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| AstraZeneca Pharmaceuticals LP | 1 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| Novo Nordisk Inc | 3 | $68 |
| ABBVIE INC. | 2 | $58 |
| Amgen Inc. | 3 | $47 |
| Lundbeck LLC | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
Products named: REXULTI, CAPLYTA, BREZTRI, Veozah, XIFAXAN, Kerendia, Ozempic, AUSTEDO XR.
Industry payments across TN — which companies pay providers there.
